维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="Protic M"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis:A global survey of physicians'practice显示文摘AIM To examine treatment decisions of gastroenterologists regarding the choice of prescribing 5-aminosalycilates(5ASA) with corticosteroids(CS) versus corticosteroids alone for patients with active ulcerative colitis(UC). METHODS A cross-sectional questionnaire exploring physicians' attitude toward 5ASA + CS combination therapy vs CS alone was developed and validated. The questionnaire was distributed to gastroenterology experts in twelve countries in five continents. Respondents' agreement with stated treatment choices were assessed by standardized Likert scale. Background professional characteristics of respondents were analyzed for correlation with responses. RESULTS Six hundred and sixty-four questionnaires were distributed and 349 received(52.6% response rate). Of 340 eligible respondents, 221(65%) would continue 5ASA in a patient hospitalized for intravenous CS treatment due to a moderate-severe UC flare, while 108(32%) would stop the 5ASA(P < 0.001), and 11(3%) are undecided. Similarly, 62% would continue 5ASA in an out-patient starting oral CS. However, only 140/340(41%) would proactively start 5ASA in a hospitalized patient not receiving 5ASA before admission. Most(94%) physicians consider the safety profile of 5ASA as very good. Only 52% consider them inexpensive, 35% perceive them to be expensive and 12% are undecided. On multi-variable analysis, less years of practice and perception of a plausible additive mechanistic effect of 5ASA + CS were positively associated with the decision to continue 5ASA with CS. CONCLUSION Despite the absence of data supporting its benefit, most gastroenterologists endorse combination of 5ASA + CS for patients with active moderate-to-severe UC. Randomized controlled trials are needed to assess if 5ASA confer any benefit for these patients.	Shomron Ben-Horin Jane M Andrews Konstantinos H Katsanos Florian Rieder Flavio Steinwurz Konstantinos Karmiris Jae Hee Cheon Gordon William Moran Monica Cesarini Christian D Stone Doron Schwartz Marijana Protic Xavier Roblin Giulia Roda Min-Hu Chen Ofir Har-Noy Charles N Bernstein	2017	World Journal of Gastroenterology2017，23，16：	3
2	Proliferating cell nuclear antigen (PCNA): ringmaster of the genome 显示文摘	Paunesku T Mittal S Protic M	2001	Int J Radiat Biol2001，77，10：	1
3	Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma显示文摘	Pugalenthi A Protic M Gonen M	2016	J Surg Oncol2016，113，2：	1
4	Uterine leiomyoma: available medical treatments and new possible therapeutic op- tions 显示文摘	Islam M S Protic O Giannubilo S R	2013	J Clin Endocrinol Metab2013，98，3：	1
5	Proliferating cell nuclear antigen (PCNA):ringmaster of the genome显示文摘	Paunesku T Mittal S Protic M	2001	Int J Radiat Biol2001，77，10：	1
6	Purification of an Ultraviolet-inducible, Damage-specific DNA-binding Protein from Primate Cells 显示文摘	Abramic M Levine A Protic M	1991	Jounal of Biological Chemistry1991，266，22：	1
7	Sensitivity to low-level radiation in radiosensitive 'wasted' mice 显示文摘	Woloschak GE Paunesku T Protic M	2002	Mil Med2002，167，2：	1
8	Postoperative complicationsand overall survival after pancreaticoduodenectomy for pancreaticductal adenocarcinoma显示文摘	Pugalenthi A Protic M Gonen M	2016	J Surg Oncol2016，113，2：	1
9	Proliferating cell nuclear antigen (PCNA):ringmaster of the genome显示文摘	Paunesku T Mittal S Protic M	2001	Int J Radiat Biol2001，77，10：	1
10	Distributed shared memory: concepts and systems 显示文摘	Protic J Tomasevic M Milutinovic V	1996	Parallel and Distributed Technology : Systems and Applications1996，4，2：	1
11	Uterine leiomyoma: available medical treatments and new possible therapeutic options显示文摘	Islam M S Protic O Giannubilo S R	2013	Clin Endocrinol Metab2013，98，3：	1
12	Proliferating cell nuclear antigen (PCNA):ringmaster of the genome显示文摘	Paunesku T Mittal S Protic M	2001	Int J Radiat Biol2001，77，10：	1
13	Proliferating cell nuclear antigen(PCNA):riognaster of the genome显示文摘	Paunesku T Mittal S Protic M	2001	Int J Radiat Biol2001，77，10：	1
14	Molecular connectivity: a novel method for prediction of bioconcentration factor of hazardous chemicals显示文摘	Sabljic A Protic M	1982	Chem Biol Interaction1982，42，3：	1
15	Proliferating cell nuclear antigen (PCNA): ringmaster of the genome 显示文摘	Paunesku T Mittal S Protic M	2001	Int J Radiat Biol2001，77，10：	1
16	Prospective clinical trial of factors predicting the early development of incisional hernia after midline laparotomy显示文摘	Veljkovic R Protic M Gluhovic A	2010	J Am Coll Surg2010，210，：	1
17	Molecular connectivity: a novel method for prediction of bioconcentration factor of hazardous chemicals 显示文摘	SABLJIC A PROTIC M	1982	Chemico Biological Interactions1982，42，：	1
18	Response of heteroge-neous ribonuclear proteins(hnRNP) to ionising radiation and their involvement in DNA damage repair显示文摘	HALEY B PAUNESKU T PROTIC M		0，，08：	1
19	Complex net- works of multiple factors in the pathogenesis of uterine leiomy- oma 显示文摘	ISLAM M S PROTIC O STORTONI P	2013	Fertility and Sterility2013，100，1：	1
20	Uterine leiomyo- ma:available medical treatments and new possible therapeu- tic options 显示文摘	Islam M S Protic O Giannubilo S R	2013	The Journal of Clinical Endocrinology&Metabolism2013，98，3：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示